InfantSEE®

The American Optometric Association (AOA) and The Vision Care Institute of Johnson & Johnson Vision Care, Inc., have partnered to create InfantSEE®, a no-cost public health program developed to provide professional eye care for infants nationwide. Through InfantSEE®, optometrists will provide a one-time, comprehensive eye assessment to infants in their first year of life, offering early detection of potential eye and vision problems at no cost regardless of income.

1 in 20,000 children have retinoblastoma (intraocular cancer) the seventh most common pediatric cancer[vi]

Clinical Data Demonstrating the Need for InfantSEE®

A study reported by the American Academy of Pediatric Ophthalmology and Strabismus (AAPOS) in 1999 compared two groups of 8-year-olds for amblyopia[vii]

One group of 808 children had been screened between the ages of 12 and 30 months and provided appropriate treatment[viii]

The other 782 children from the same community did not receive the infant screening[ix]

At age 8, the group that did not receive the infant screening was 17 times more likely to have amblyopia[x]

The Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC) reported that intensive screening performed 6 times between ages 8 months and 37 months by an eye-care professional led to a decrease in[xi]:

Amblyopia, which was three times less likely after treatment – from 1.8 percent to 0.6 percent [xii]

Residual amblyopia from 25 percent to 7.5 percent after treatment[xiii]

Current red reflex screening appears to be ineffective in detecting early retinoblastoma as over 80 percent of patients had their presenting sign detected by a family member or friend[xiv]

Untreated amblyopia costs the U.S. nearly $7.4 billion in earning power each year. There is a return of $22 for each dollar spent on amblyopia diagnosis and treatment [xv]

To learn more about InfantSEE® visit www.infantsee.org or call toll-free (888) 396-EYES (3937).